viewHeritage Cannabis Holdings Corp.

Heritage Cannabis generates FY2020 revenue of $9.3M on third-party contract sales

The company said its business accelerated in 2020 despite the pandemic and Heritage Cannabis expects to be well on its way to profitability this year

Heritage Cannabis Holdings Corp. -
Heritage Cannabis said it is focused on the success of its existing products as well as near-term medical product launches

Heritage Cannabis Holdings Corp (CSE:CANN) (OTCQX:HERTF) (FRA:2UE) reported fiscal 2020 gross revenue of $9.3 million, even as COVID-19 weighed on the company’s first full year of sales. 

Heritage Cannabis noted that its revenue in FY2020 was composed primarily of proceeds from third-party contracts, as branded provincial sales didn’t start until late 2020. 

“During the past year, we continued to build the foundation of our company by moving the focus toward introducing our own brands and capacity expansion, and making acquisitions to support our long-term vision of delivering sustainable value to shareholders,” Heritage Cannabis Holdings CEO Clint Sharples said in a statement.

READ: Heritage Cannabis is pioneering the seed-to-sale cannabis model

He added: “The business definitely accelerated in 2020 despite the challenges brought on by the pandemic, and we expect to be well on our way to profitability this year with the integration of the recent acquisitions of Premium 5 and Opticann.”

“The combined group under the Heritage banner is focused on the success of our existing products, expanding SKUs across Canada, as well as near-term medical product launches.”

Heritage Cannabis also recorded a net loss for the year that narrowed to $0.02 per share, from $0.03 in 2019, as the company continued to use its cash resources to scale the business during the year. It is in the process of completing a financing subsequent to the year-end.  

Among the company’s notable accomplishments for 2020 was its acquisition of Opticann Inc, a Colorado-based oral and topical cannabinoid company, for an initial consideration of up to $3.7 million in stock. Opticann has the rights to exclusively sell CBD and CBG products made with the patented VESIsorb drug delivery system for optimized absorption and stability through a supply and distribution agreement with Geocann LLC. 

Heritage Cannabis is a vertically-integrated cannabis provider that currently has two Health Canada-approved licensed producers, through its subsidiaries Voyage Cannabis Corp and CannaCure Corp, both of which are regulated under the Cannabis Act Regulations. 

The company recently acquired Canadian recreational and medical cannabis company Premium 5 Ltd, which Heritage Cannabis expects will make it a leader in the extract and extract derivatives market, as Premium 5 is a premium provider of Cannabis 2.0 hydrocarbon and solventless concentrates in Canada. 

Contact Sean at sean@proactiveinvestors.com

Quick facts: Heritage Cannabis Holdings Corp.


Price: 0.07 CAD

Market Cap: $54.81 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...


Heritage Cannabis sets new monthly record with 3.2 million dollars in sales

Heritage Cannabis CEO David Schwede joined Steve Darling from Proactive to share news the company is continuing to set records in sales. Unaudited sales for July, 2021 saw a monthly record of $3.2-million dollars. That marks the 5th monthly sales record in 2021. Schwede telling Proactive the...

4 weeks ago

2 min read